PSMD1 and COVID-19: Reasons explaining the lower median titers of both anti-S1 and anti-NCP antibodies in CoronaVac responses compared to (severe) COVID-19 cases may include the lower amount of virus in the vaccine, while high viral loads in severely diseased patients cause a stronger increase in post-infection antibody levels [38].